Alzheimer’s disease (AD) is the most common form of dementia,
affects an estimated 5.3 million people in the United States and is
the only 1 of the top 10 causes-of-death with no disease-altering
treatments (Ridge et al., 2013a). Most of the affected individuals
succumb to disease within 7 years of diagnosis. As the disease
progresses, affected individuals eventually require fulltime care,
which exacts a substantial emotional and economic burden on
families of affected individuals and society at large. Currently, AD